All Things Investigations – Navigating Secondary Tariffs with Mike Huneke and Brent Carlson
FCPA Compliance Report: The Impact of Secondary Tariffs on Global Trade with Mike Huneke and Brent Carlson
10 For 10: Top Compliance Stories For the Week Ending June 14, 2025
Daily Compliance News: June 9, 2025, The Repugnant Edition
Compliance in the Former Soviet Central Asian Republics
Episode 330 – Halyna Senyk on Anti-Corruption Progress in Ukraine
FINCast Ep. 39 – State of Russia Sanctions Two Years After the Invasion
Season 2 Episode 4 - Russia Enforcement and the involvement of DOJ's Task Force KleptoCapture
The Justice Insiders Podcast: The Latest on Russia Sanctions and the Enhanced Enforcement Environment
Episode 271 -- Deep Dive into Microsoft's OFAC Settlement for $3 Million
The New Cold War: Risk, Sanctions, Compliance Episode 27: “The Yukos Case: 20 Years Later”
The New Cold War: Risk, Sanctions, Compliance Episode 26: “International Sports: Politics, Corruption, Doping and Compliance”
The New Cold War: Risk, Sanctions, Compliance Episode 25: “Can the U.S. Seize the Russian Central Bank’s Assets?”
The New Cold War: Risk, Sanctions, Compliance Episode 23: "Former FBI Acting Director Andrew McCabe”
The New Cold War: Risk, Sanctions, Compliance Episode 20: "Rich Russians: From Oligarchs to Bourgeoisie"
The New Cold War: Risk, Sanctions, Compliance Episode 19: “Psychological Profiling, Crisis Management, and the New Cold War”
Compliance in Ukraine
FINCast Ep. 34 - A Storied Journey in the World of Financial Integrity: A Conversation with Stuart Levey
Putin's Oil Heist - Episode 5: Fighting From Afar
FCPA Compliance Report - Josh Fitzhugh on Trade Compliance Since the Russian Invasion of Ukraine
As the third month of the second Trump administration comes to a close, the lack of any public enforcement action by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) has sanctions watchers...more
Last week, the SEC added another pharmaceutical company to its list of FCPA violators when AstraZeneca agreed to a $5.5 million settlement with the SEC. AZ is now the 25th drug or medical device company to pay an FCPA penalty...more
Despite a decline in enforcement actions by the Securities Exchange Commission (“SEC”) and the Department of Justice (“DOJ”), the first half of 2015 has continued to highlight the relevance and ever-evolving effects of the...more